Faizah, Z.; Amanda, B.; Ashari, F.Y.; Triastuti, E.; Oxtoby, R.; Rahaju, A.S.; Aziz, M.A.; Lusida, M.I.; Oceandy, D.
Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice. Molecules 2020, 25, 4381.
https://doi.org/10.3390/molecules25194381
AMA Style
Faizah Z, Amanda B, Ashari FY, Triastuti E, Oxtoby R, Rahaju AS, Aziz MA, Lusida MI, Oceandy D.
Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice. Molecules. 2020; 25(19):4381.
https://doi.org/10.3390/molecules25194381
Chicago/Turabian Style
Faizah, Zakiyatul, Bella Amanda, Faisal Yusuf Ashari, Efta Triastuti, Rebecca Oxtoby, Anny Setijo Rahaju, M. Aminudin Aziz, Maria Inge Lusida, and Delvac Oceandy.
2020. "Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice" Molecules 25, no. 19: 4381.
https://doi.org/10.3390/molecules25194381
APA Style
Faizah, Z., Amanda, B., Ashari, F. Y., Triastuti, E., Oxtoby, R., Rahaju, A. S., Aziz, M. A., Lusida, M. I., & Oceandy, D.
(2020). Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice. Molecules, 25(19), 4381.
https://doi.org/10.3390/molecules25194381
